Innovative approaches to treat pancreatic cancer
Washington University SPORE in Pancreatic Cancer
This study is working to find better ways to diagnose and treat pancreatic cancer by bringing together experts to develop new treatments and improve care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10916333 on NIH RePORTER |
What this research studies
This research focuses on pancreatic ductal adenocarcinoma (PDAC), the most lethal form of pancreatic cancer. It brings together experts in immunology, cancer biology, and drug development to create new diagnostic and therapeutic strategies. The program includes multiple research projects and shared resources aimed at improving patient outcomes through innovative clinical trials. By leveraging advanced techniques in genomics and biostatistics, the team aims to develop targeted therapies that can significantly impact the treatment landscape for PDAC.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma who are seeking novel treatment options.
Not a fit: Patients with other types of cancer or those who are not diagnosed with pancreatic ductal adenocarcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and improved survival rates for patients with pancreatic cancer.
How similar studies have performed: Previous research in immunologic therapies for pancreatic cancer has shown promise, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Denardo, David G — Washington University
- Study coordinator: Denardo, David G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.